Original Source(s)
Related Content
Pregnancy Risks With First Trimester GLP-1 Continuation
Claims-based target trial emulation found no clear association between continued GLP-1 receptor agonist use in early pregnancy and nonlive birth, fetal growth abnormalities, or major congenital malformations.
June 17, 2026
-
3 min
Beta-2 Agonists Tied to ASD Risk?
Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.
June 24, 2026
-
4 min